Effects of biogenic monoamines and precursors on stress ulcers and secretion in stomach.
D006916:5-Hydroxytryptophan / Q000627:therapeutic use; D000588:Amines / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D005750:Gastric Juice / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007490:Iproniazid / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000627:therapeutic use; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013270:Stomach / Q000187:drug effects*; D013276:Stomach Ulcer / Q000188:drug therapy*
D000588:Amines; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D006916:5-Hydroxytryptophan; D007490:Iproniazid; D004298:Dopamine; D009638:Norepinephrine